Anil K. Jaiswal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anil K. Jaiswal has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Saravanakumar Dhakshinamoorthy
Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77030, USA
3 shared publicationsDavid A. Bloom
Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77030
2 shared publicationsDelwin J. Long
Department of Pharmacology, Baylor College of Medicine, Houston, TX, USA
2 shared publicationsKarim Iskander
Department of Pharmacology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas
2 shared publicationsVenugopal Radjendirane
Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030, USA
2 shared publications- Abhinav K. Jain
Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, USA
1 shared publication
Latest Publications
- RetractedOpen Access
- 1 June 2007
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (11) , 5380-5388
NRH:Quinone Oxidoreductase 2 and NAD(P)H:Quinone Oxidoreductase 1 Protect Tumor Suppressor p53 against 20S Proteasomal Degradation Leading to Stabilization and Activation of p53
Tumor suppressor p53 is either lost or mutated in several types of cancer. MDM2 interaction with p53 results in ubiquitination and 26S proteasomal degradation of p53. Chronic DNA damage leads to inactivation of MDM2, stabilization of p53, and apoptotic cell death. Here, we present a novel MDM2/ubiquitination-independent mechanism of stabilization and transient activation of p53. The present studies show that 20S proteasomes degrade p53. The 20S degradation of p53 was observed in ubiquitin-efficient and -deficient cells, indicating that this pathway of degradation did not require ubiquitination of p53. The cytosolic quinone oxidoreductases [NRH:quinone oxidoreductase 2 (NQO2) and NAD(P)H:quinone oxidoreductase 1 (NQO1)] interacted with p53 and protected p53 against 20S proteasomal degradation. Further studies revealed that acute exposure to radiation or chemical leads to induction of NQO1 and NQO2 that stabilizes and transiently activates p53 and downstream genes. These results suggest that stress-induced NQO1 and NQO2 transiently stabilize p53, which leads to protection against adverse effects of stressors. [Cancer Res 2007;67(11):5380–8]
- 1 June 2007
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (11) , 5380-5388
RetractedOpen AccessNRH:Quinone Oxidoreductase 2 and NAD(P)H:Quinone Oxidoreductase 1 Protect Tumor Suppressor p53 against 20S Proteasomal Degradation Leading to Stabilization and Activation of p53
Tumor suppressor p53 is either lost or mutated in several types of cancer. MDM2 interaction with p53 results in ubiquitination and 26S proteasomal degradation of p53. Chronic DNA damage leads to inactivation of MDM2, stabilization of p53, and apoptotic cell death. Here, we present a novel MDM2/ubiquitination-independent mechanism of stabilization and transient activation of p53. The present studies show that 20S proteasomes degrade p53. The 20S degradation of p53 was observed in ubiquitin-efficient and -deficient cells, indicating that this pathway of degradation did not require ubiquitination of p53. The cytosolic quinone oxidoreductases [NRH:quinone oxidoreductase 2 (NQO2) and NAD(P)H:quinone oxidoreductase 1 (NQO1)] interacted with p53 and protected p53 against 20S proteasomal degradation. Further studies revealed that acute exposure to radiation or chemical leads to induction of NQO1 and NQO2 that stabilizes and transiently activates p53 and downstream genes. These results suggest that stress-induced NQO1 and NQO2 transiently stabilize p53, which leads to protection against adverse effects of stressors. [Cancer Res 2007;67(11):5380–8]
- RetractedOpen Access
- 1 September 2006
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (17) , 8421-8429
Low and High Dose UVB Regulation of Transcription Factor NF-E2-Related Factor 2
Transcription factor NF-E2-related factor 2 (Nrf2) regulates antioxidant response element (ARE)–mediated expression and coordinated induction of chemoprotective proteins in response to chemical stress. In this report, we investigated Nrf2 response to low and high dose UVB irradiation. Low dose (7.5 J/m2) UVB exposure of mouse hepatoma, mouse keratinocyte, and human skin fibroblast cells led to the nuclear accumulation of Nrf2 and up-regulation of ARE-mediated gene expression. On the contrary, and intriguingly, high dose (20 J/m2) UVB exposure of cells led to the nuclear exclusion of Nrf2 and down-regulation of chemoprotective gene expression with possible implications in UVB carcinogenesis. We investigated the mechanism by which high dose UVB induced the nuclear exclusion of Nrf2. Prior treatment with nuclear export inhibitor, leptomycin B, abrogated the UVB-induced nuclear exclusion of Nrf2, indicating that the decrease of Nrf2 in the nucleus was due to the nuclear export of Nrf2. High dose UVB increased the phosphorylation of Nrf2Y568 which stimulated the nuclear export of Nrf2. Mutation of Nrf2Y568 to phenylalanine and src kinase inhibitor PP2 abrogated/reduced the UVB-induced phosphorylation of Nrf2Y568 and nuclear exclusion of Nrf2. Transfection with src family member Fyn small interfering RNA resulted in the nuclear accumulation of Nrf2 and an increase in the expression and UVB induction of ARE-mediated gene expression. UVB exposure also induced the nuclear localization of Fyn. These results suggest that high dose UVB induced the activation/nuclear localization of Fyn which led to increased phosphorylation of Nrf2Y568 and enhanced nuclear export of Nrf2. This resulted in nuclear exclusion of Nrf2 and down-regulation of ARE-mediated chemoprotective gene expression. (Cancer Res 2006; 66(17): 8421-9)
- 1 September 2006
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (17) , 8421-8429
RetractedOpen AccessLow and High Dose UVB Regulation of Transcription Factor NF-E2-Related Factor 2
Transcription factor NF-E2-related factor 2 (Nrf2) regulates antioxidant response element (ARE)–mediated expression and coordinated induction of chemoprotective proteins in response to chemical stress. In this report, we investigated Nrf2 response to low and high dose UVB irradiation. Low dose (7.5 J/m2) UVB exposure of mouse hepatoma, mouse keratinocyte, and human skin fibroblast cells led to the nuclear accumulation of Nrf2 and up-regulation of ARE-mediated gene expression. On the contrary, and intriguingly, high dose (20 J/m2) UVB exposure of cells led to the nuclear exclusion of Nrf2 and down-regulation of chemoprotective gene expression with possible implications in UVB carcinogenesis. We investigated the mechanism by which high dose UVB induced the nuclear exclusion of Nrf2. Prior treatment with nuclear export inhibitor, leptomycin B, abrogated the UVB-induced nuclear exclusion of Nrf2, indicating that the decrease of Nrf2 in the nucleus was due to the nuclear export of Nrf2. High dose UVB increased the phosphorylation of Nrf2Y568 which stimulated the nuclear export of Nrf2. Mutation of Nrf2Y568 to phenylalanine and src kinase inhibitor PP2 abrogated/reduced the UVB-induced phosphorylation of Nrf2Y568 and nuclear exclusion of Nrf2. Transfection with src family member Fyn small interfering RNA resulted in the nuclear accumulation of Nrf2 and an increase in the expression and UVB induction of ARE-mediated gene expression. UVB exposure also induced the nuclear localization of Fyn. These results suggest that high dose UVB induced the activation/nuclear localization of Fyn which led to increased phosphorylation of Nrf2Y568 and enhanced nuclear export of Nrf2. This resulted in nuclear exclusion of Nrf2 and down-regulation of ARE-mediated chemoprotective gene expression. (Cancer Res 2006; 66(17): 8421-9)
- Retracted
- 25 July 2006
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 162 (1) , 81-87
RETRACTED: Si RNA inhibition of GRP58 associated with decrease in mitomycin C-induced DNA cross-linking and cytotoxicity
- 25 July 2006
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 162 (1) , 81-87
RetractedRETRACTED: Si RNA inhibition of GRP58 associated with decrease in mitomycin C-induced DNA cross-linking and cytotoxicity
- Open Access
- 1 April 2005
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (17) , 16891-16900
Bach1 Competes with Nrf2 Leading to Negative Regulation of the Antioxidant Response Element (ARE)-mediated NAD(P)H:Quinone Oxidoreductase 1 Gene Expression and Induction in Response to Antioxidants
- 1 April 2005
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (17) , 16891-16900
Open AccessBach1 Competes with Nrf2 Leading to Negative Regulation of the Antioxidant Response Element (ARE)-mediated NAD(P)H:Quinone Oxidoreductase 1 Gene Expression and Induction in Response to Antioxidants
- 15 October 2004
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 37 (8) , 1231-1243
Sp3 repression of polymorphic human NRH:quinone oxidoreductase 2 gene promoter
- 15 October 2004
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 37 (8) , 1231-1243
Sp3 repression of polymorphic human NRH:quinone oxidoreductase 2 gene promoter
- 1 September 2004
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (17) , 5925-5928
Deficiency of NRH:Quinone Oxidoreductase 2 Increases Susceptibility to 7,12-Dimethylbenz( a )anthracene and Benzo( a )pyrene-Induced Skin Carcinogenesis
NRH:Quinone oxidoreductase 2 (NQO2) is an enzyme that catalyzes the reductive metabolism of quinones. C57BL/6 NQO2−/− mice lacking NQO2 gene expression were generated in our laboratory. The dorsal skin of NQO2-deficient mice was exposed to 7,12-dimethylbenz(a)anthracene (DMBA) or benzo(a)pyrene alone (complete carcinogen) or with 12-O-tetradecanoylphorbol-13-acetate (TPA) (initiation/promotion model) to determine the in vivo role of NQO2 in chemical carcinogenesis. The NQO2−/− mice showed significantly increased tumor frequency with DMBA + TPA when compared with their wild-type littermates. The benzo(a)pyrene + TPA also showed increase in tumor incidence in NQO2−/− mice but to a less extent than DMBA. DMBA alone resulted in low frequency of tumor development with no difference in susceptibility between wild-type and NQO2−/− mice. Benzo(a)pyrene alone failed to induce tumors in either wild-type or NQO2−/− mice. Histologic analysis of the NQO2−/− mice tumors demonstrated proliferative activity. The treatment of NQO2−/− mice skin with benzo(a)pyrene failed to significantly increase tumor suppressor protein p53 and p53-regulated growth-related protein p21 and proapoptotic protein Bax as observed in case of wild-type mice. These results demonstrate that NQO2 protects against DMBA- and benzo(a)pyrene-induced skin carcinogenesis and suggest that NQO2 protection might be against tumor promotion. The results also suggest that lack of induction of p53, p21, and Bax proteins might contribute to increased sensitivity of NQO2−/− mice skin to benzo(a)pyrene carcinogenicity.
- 1 September 2004
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (17) , 5925-5928
Deficiency of NRH:Quinone Oxidoreductase 2 Increases Susceptibility to 7,12-Dimethylbenz( a )anthracene and Benzo( a )pyrene-Induced Skin Carcinogenesis
NRH:Quinone oxidoreductase 2 (NQO2) is an enzyme that catalyzes the reductive metabolism of quinones. C57BL/6 NQO2−/− mice lacking NQO2 gene expression were generated in our laboratory. The dorsal skin of NQO2-deficient mice was exposed to 7,12-dimethylbenz(a)anthracene (DMBA) or benzo(a)pyrene alone (complete carcinogen) or with 12-O-tetradecanoylphorbol-13-acetate (TPA) (initiation/promotion model) to determine the in vivo role of NQO2 in chemical carcinogenesis. The NQO2−/− mice showed significantly increased tumor frequency with DMBA + TPA when compared with their wild-type littermates. The benzo(a)pyrene + TPA also showed increase in tumor incidence in NQO2−/− mice but to a less extent than DMBA. DMBA alone resulted in low frequency of tumor development with no difference in susceptibility between wild-type and NQO2−/− mice. Benzo(a)pyrene alone failed to induce tumors in either wild-type or NQO2−/− mice. Histologic analysis of the NQO2−/− mice tumors demonstrated proliferative activity. The treatment of NQO2−/− mice skin with benzo(a)pyrene failed to significantly increase tumor suppressor protein p53 and p53-regulated growth-related protein p21 and proapoptotic protein Bax as observed in case of wild-type mice. These results demonstrate that NQO2 protects against DMBA- and benzo(a)pyrene-induced skin carcinogenesis and suggest that NQO2 protection might be against tumor promotion. The results also suggest that lack of induction of p53, p21, and Bax proteins might contribute to increased sensitivity of NQO2−/− mice skin to benzo(a)pyrene carcinogenicity.
- Open Access
- 1 November 2003
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (45) , 44675-44682
Phosphorylation of Nrf2 at Ser40 by Protein Kinase C in Response to Antioxidants Leads to the Release of Nrf2 from INrf2, but Is Not Required for Nrf2 Stabilization/Accumulation in the Nucleus and Transcriptional Activation of Antioxidant Response Element-mediated NAD(P)H:Quinone Oxidoreductase-1 Gene Expression
- 1 November 2003
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (45) , 44675-44682
Open AccessPhosphorylation of Nrf2 at Ser40 by Protein Kinase C in Response to Antioxidants Leads to the Release of Nrf2 from INrf2, but Is Not Required for Nrf2 Stabilization/Accumulation in the Nucleus and Transcriptional Activation of Antioxidant Response Element-mediated NAD(P)H:Quinone Oxidoreductase-1 Gene Expression
- 2 August 2002
- Published by Springer Nature in Oncogene
- Vol. 21 (34) , 5301-5312
c-Maf negatively regulates ARE-mediated detoxifying enzyme genes expression and anti-oxidant induction
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.
- 2 August 2002
- Published by Springer Nature in Oncogene
- Vol. 21 (34) , 5301-5312
c-Maf negatively regulates ARE-mediated detoxifying enzyme genes expression and anti-oxidant induction
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.
- 28 March 2002
- Published by Springer Nature in Oncogene
- Vol. 21 (14) , 2191-2200
Site-directed mutagenesis of cysteine to serine in the DNA binding regionof Nrf2 decreases its capacity to upregulate antioxidant responseelement-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.
- 28 March 2002
- Published by Springer Nature in Oncogene
- Vol. 21 (14) , 2191-2200
Site-directed mutagenesis of cysteine to serine in the DNA binding regionof Nrf2 decreases its capacity to upregulate antioxidant responseelement-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.
- Open Access
- 1 August 2001
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 93 (15) , 1166-1170
NAD(P)H : quinone Oxidoreductase 1 Deficiency and Increased Susceptibility to 7,12-Dimethylbenz[a]-anthracene-Induced Carcinogenesis in Mouse Skin
Background: The phase II enzyme NAD(P)H : quinone oxidoreductase 1 (NQO1) catalyzes quinone detoxification, protecting cells from redox cycling, oxidative stress, mutagenicity, and cytotoxicity induced by quinones and its precursors. We have used NQO1−/− C57BL/6 mice to show that NQO1 protects them from skin cancer induced by the polycyclic aromatic hydrocarbon benzo[a]pyrene. Herein, we used NQO1−/− mice to investigate whether NQO1 also protects them against 7,12-dimethylbenz[a]anthracene (DMBA), where methyl substituents diminish primary quinone formation. Methods: Dorsal skin of NQO1−/− or wild-type C57BL/6 mice was shaved. When tested as a complete carcinogen, DMBA (500 or 750 μg in 100 μL of acetone) alone was applied to the shaved area. When tested as a tumor initiator, DMBA (200 or 400 nmol in 100 μL of acetone) was applied to the shaved area; 1 week later, twice-weekly applications of phorbol 12-myristate 13-acetate (PMA)—10 μg dissolved in 200 μL of acetone—to the same area began and were continued for 20 weeks. Tumor development was monitored in all mice (12–15 per group). All statistical tests were two-sided. Results: When DMBA (750 μg) was tested as a complete carcinogen, about 50% of the DMBA-treated NQO1−/− mice but no DMBA-treated wild-type mouse developed skin tumors. When DMBA (both concentrations) was used as a tumor initiator, NQO1−/− mice developed larger tumors at a greater frequency than their wild-type littermates. Twenty-three weeks after the first PMA treatment in the tumor initiator test, all 30 NQO1−/− mice given 400 nmol of DMBA had developed skin tumors, compared with 33% (10 of 30) of treated wild-type mice (P<.001). Conclusions: NQO1−/− mice are more susceptible to DMBA-induced skin cancer than are their wild-type littermates, suggesting that NQO1 may protect cells from DMBA carcinogenesis.
- 1 August 2001
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 93 (15) , 1166-1170
Open AccessNAD(P)H : quinone Oxidoreductase 1 Deficiency and Increased Susceptibility to 7,12-Dimethylbenz[a]-anthracene-Induced Carcinogenesis in Mouse Skin
Background: The phase II enzyme NAD(P)H : quinone oxidoreductase 1 (NQO1) catalyzes quinone detoxification, protecting cells from redox cycling, oxidative stress, mutagenicity, and cytotoxicity induced by quinones and its precursors. We have used NQO1−/− C57BL/6 mice to show that NQO1 protects them from skin cancer induced by the polycyclic aromatic hydrocarbon benzo[a]pyrene. Herein, we used NQO1−/− mice to investigate whether NQO1 also protects them against 7,12-dimethylbenz[a]anthracene (DMBA), where methyl substituents diminish primary quinone formation. Methods: Dorsal skin of NQO1−/− or wild-type C57BL/6 mice was shaved. When tested as a complete carcinogen, DMBA (500 or 750 μg in 100 μL of acetone) alone was applied to the shaved area. When tested as a tumor initiator, DMBA (200 or 400 nmol in 100 μL of acetone) was applied to the shaved area; 1 week later, twice-weekly applications of phorbol 12-myristate 13-acetate (PMA)—10 μg dissolved in 200 μL of acetone—to the same area began and were continued for 20 weeks. Tumor development was monitored in all mice (12–15 per group). All statistical tests were two-sided. Results: When DMBA (750 μg) was tested as a complete carcinogen, about 50% of the DMBA-treated NQO1−/− mice but no DMBA-treated wild-type mouse developed skin tumors. When DMBA (both concentrations) was used as a tumor initiator, NQO1−/− mice developed larger tumors at a greater frequency than their wild-type littermates. Twenty-three weeks after the first PMA treatment in the tumor initiator test, all 30 NQO1−/− mice given 400 nmol of DMBA had developed skin tumors, compared with 33% (10 of 30) of treated wild-type mice (P<.001). Conclusions: NQO1−/− mice are more susceptible to DMBA-induced skin cancer than are their wild-type littermates, suggesting that NQO1 may protect cells from DMBA carcinogenesis.